CHA News Article

Medical Board of California Issues FAQs on CURES
Mandatory compliance begins Oct. 2

A new frequently asked questions document from the Medical Board of California addresses key concerns related to mandatory consultation of the Controlled Substance Utilization Review and Evaluation System (CURES). CURES is a database that contains records of prescriptions for Schedule II, III and IV controlled substances dispensed in the state. The Medical Board document defines “mandatory use,” clarifies the actions that constitute consultation, and explains whether prescribers may use proxy or delegate staff to meet these requirements.

As previously reported in CHA News, Senate Bill 482 (Chapter 708, Statutes of 2016) required health practitioners to consult their patients’ histories in CURES before prescribing them a Schedule II, III or IV controlled substance for the first time, and then at least once every four months as long as the prescription continued to be renewed. Consultation is not required when controlled substances are administered to inpatients or to certain other patients treated in a health facility. The bill’s requirements take effect Oct. 2.

Commands